In fact, these cell percentages and insulin dose values at T1D onset, separated by remitters and non-remitters, showed how those remitter patients were diagnosed with lower percentages of TREG (P <0.01) and monocytes (P ≤0.05), a higher percentage of DCs (P ≤0.05), and lower doses of exogenous insulin (P <0.01) compared to those non-remitter patients (Figures 9A–D). The gene discussed is INS; the disease is type 1 diabetes mellitus.